The DNA methylation landscape in cancer

被引:213
作者
Skvortsova, Ksenia [1 ,2 ]
Stirzaker, Clare [1 ,2 ]
Taberlay, Phillippa [3 ]
机构
[1] Garvan Inst Med Res, Genom & Epigenet Div, Sydney, NSW 2010, Australia
[2] UNSW Australia, St Vincents Clin Sch, Sydney, NSW 2010, Australia
[3] Univ Tasmania, Sch Med, Coll Hlth & Med, Hobart, Tas 7001, Australia
来源
DNA METHYLATION | 2019年 / 63卷 / 06期
基金
英国医学研究理事会;
关键词
BASE-RESOLUTION ANALYSIS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; IDH2; MUTATIONS; TET PROTEINS; EPIGENETIC EVENTS; ENHANCER ACTIVITY; HIGH-THROUGHPUT; X-CHROMOSOME; CPG-ISLANDS;
D O I
10.1042/EBC20190037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As one of the most abundant and well-studied epigenetic modifications, DNA methylation plays an essential role in normal development and cellular biology. Global alterations to the DNA methylation landscape contribute to alterations in the transcriptome and deregulation of cellular pathways. Indeed, improved methods to study DNA methylation patterning and dynamics at base pair resolution and across individual DNA molecules on a genome-wide scale has highlighted the scope of change to the DNA methylation landscape in disease states, particularly during tumorigenesis. More recently has been the development of DNA hydroxymethylation profiling techniques, which allows differentiation between 5mC and 5hmC profiles and provides further insights into DNA methylation dynamics and remodeling in tumorigenesis. In this review, we describe the distribution of DNA methylation and DNA hydroxymethylation in different genomic contexts, first in normal cells, and how this is altered in cancer. Finally, we discuss DNA methylation profiling technologies and the most recent advances in single-cell methods, bisulfite-free approaches and ultra-long read sequencing techniques.
引用
收藏
页码:797 / 811
页数:15
相关论文
共 146 条
  • [1] Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
    Abdel-Wahab, Omar
    Mullally, Ann
    Hedvat, Cyrus
    Garcia-Manero, Guillermo
    Patel, Jay
    Wadleigh, Martha
    Malinge, Sebastien
    Yao, JinJuan
    Kilpivaara, Outi
    Bhat, Rukhmi
    Huberman, Kety
    Thomas, Sabrena
    Dolgalev, Igor
    Heguy, Adriana
    Paietta, Elisabeth
    Le Beau, Michelle M.
    Beran, Miloslav
    Tallman, Martin S.
    Ebert, Benjamin L.
    Kantarjian, Hagop M.
    Stone, Richard M.
    Gilliland, D. Gary
    Crispino, John D.
    Levine, Ross L.
    [J]. BLOOD, 2009, 114 (01) : 144 - 147
  • [2] Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer
    Akhtar-Zaidi, Batool
    Lari, Richard Cowper-Sal
    Corradin, Olivia
    Saiakhova, Alina
    Bartels, Cynthia F.
    Balasubramanian, Dheepa
    Myeroff, Lois
    Lutterbaugh, James
    Jarrar, Awad
    Kalady, Matthew F.
    Willis, Joseph
    Moore, Jason H.
    Tesar, Paul J.
    Laframboise, Thomas
    Markowitz, Sanford
    Lupien, Mathieu
    Scacheri, Peter C.
    [J]. SCIENCE, 2012, 336 (6082) : 736 - 739
  • [3] Nucleosomes are well positioned in exons and carry characteristic histone modifications
    Andersson, Robin
    Enroth, Stefan
    Rada-Iglesias, Alvaro
    Wadelius, Claes
    Komorowski, Jan
    [J]. GENOME RESEARCH, 2009, 19 (10) : 1732 - 1741
  • [4] Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity
    Angermueller, Christof
    Clark, Stephen J.
    Lee, Heather J.
    Macaulay, Iain C.
    Teng, Mabel J.
    Hu, Tim Xiaoming
    Krueger, Felix
    Smallwood, Sebastien A.
    Ponting, Chris P.
    Voet, Thierry
    Kelsey, Gavin
    Stegle, Oliver
    Reik, Wolf
    [J]. NATURE METHODS, 2016, 13 (03) : 229 - +
  • [5] DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes
    Aran, Dvir
    Sabato, Sivan
    Hellman, Asaf
    [J]. GENOME BIOLOGY, 2013, 14 (03)
  • [6] A decade of exploring the cancer epigenome - biological and translational implications
    Baylin, Stephen B.
    Jones, Peter A.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (10) : 726 - 734
  • [7] Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis
    Belinsky, SA
    Nikula, KJ
    Palmisano, WA
    Michels, R
    Saccomanno, G
    Gabrielson, E
    Baylin, SB
    Herman, JG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 11891 - 11896
  • [8] Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains
    Berman, Benjamin P.
    Weisenberger, Daniel J.
    Aman, Joseph F.
    Hinoue, Toshinori
    Ramjan, Zachary
    Liu, Yaping
    Noushmehr, Houtan
    Lange, Christopher P. E.
    van Dijk, Cornelis M.
    Tollenaar, Rob A. E. M.
    Van den Berg, David
    Laird, Peter W.
    [J]. NATURE GENETICS, 2012, 44 (01) : 40 - U62
  • [9] Regional Activation of the Cancer Genome by Long-Range Epigenetic Remodeling
    Bert, Saul A.
    Robinson, Mark D.
    Strbenac, Dario
    Statham, Aaron L.
    Song, Jenny Z.
    Hulf, Toby
    Sutherland, Robert L.
    Coolen, Marcel W.
    Stirzaker, Clare
    Clark, Susan J.
    [J]. CANCER CELL, 2013, 23 (01) : 9 - 22
  • [10] CLONING OF A MAMMALIAN DNA METHYLTRANSFERASE
    BESTOR, TH
    [J]. GENE, 1988, 74 (01) : 9 - 12